What's New

Last Posted: Dec 09, 2023

• Association of Endothelial Nitric Oxide Synthase and Angiotensin-Converting Enzyme Genes Polymorphism With In-Sent Restenosis of Bare Metal Stents vs Drug-Eluting Stents in Egyptians.
  Tarek A Abdelaziz, et al. Angiology 2023 0 33197231219837
• Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients.
  Yu-Ling Hsu et al. BMC Geriatr 2023 23(1) 443
• Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents in East Asian Patients: Results From the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) Consortium.
  Soo-Jin Kim, et al. Journal of the American Heart Association 2023 0 (9) e027804
• CYP2C192 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.
  Ruedlinger Jenny, et al. BioMed research international 2017 0 5783719
• Accelerated Atherogenicity in Tangier Disease.
  Muratsu Jun, et al. Journal of atherosclerosis and thrombosis 2018 0 (10) 1076-1085
• Coronary stent restenosis and the association with allergy to metal content of 316L stainless steel.
  Slodownik D, et al. Cardiovascular journal of Africa 2018 0 (1) 43-45
• Long-term safety of drug-coated devices for peripheral revascularisation.
  Secemsky Eric A, et al. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2020 0 (7) 590-598
• The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention.
  Wang Tingting, et al. European journal of clinical pharmacology 2021 0 (11) 1679-1686
• Self-expanding metal stent placement and pathological alterations among obstructive colorectal cancer cases.
  Kosumi Keisuke, et al. World journal of gastrointestinal endoscopy 2022 0 (11) 704-717
• Biliary obstruction and pancreatitis after duodenal stent placement in the descending duodenum: a retrospective study.
  Kaneko Junichi, et al. BMC gastroenterology 2022 0 (1) 257
• Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.
  Joo Hyung Joon, et al. Scientific reports 2018 0 (1) 1229
• [Not Available].
  Mansurova J A, et al. Kardiologiia 2019 0 (12) 22-29
• Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.
  Toba Takayoshi, et al. Heart and vessels 2019 0 (6) 936-947
• Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis.
  Köster R, et al. Lancet (London, England) 2000 0 (9245) 1895-7
• Single-nucleotide polymorphism of ADR?2 and CDKN1B genes in Egyptian patients with coronary artery in-stent restenosis.
  Abdelaziz Tarek A, et al. Coronary artery disease 2022 1
• Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents.
  Liu Yen-Wen, et al. iScience 2021 9 (9) 103082
• Automatic detection of vessel structure by deep learning using intravascular ultrasound images of the coronary arteries.
  Shinohara Hiroki et al. PloS one 2021 16(8) e0255577
• Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease.
  Azova Madina, et al. Biomolecules 2021 5 (5)
• A machine learning-based approach for the prediction of periprocedural myocardial infarction by using routine data.
  Wang Yao et al. Cardiovascular diagnosis and therapy 2020 Oct 10(5) 1313-1324
• Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2.
  Watanabe Hirotoshi, et al. Cardiovascular intervention and therapeutics 2020 11
• Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics.
  Sampedro-Gómez Jesús et al. The Canadian journal of cardiology 2020 Feb
• Impact of CYP2D6 polymorphisms on tamoxifen treatment in patients with retroperitoneal fibrosis: A first step towards tailored therapy?
  Dreger Nici Markus et al. Urology 2019 Dec
• The association between genetic polymorphisms of the interleukin-10, tumor necrosis factor-alpha, and annexin A5 gene loci and restenosis after percutaneous coronary angioplasty and stenting.
  Hashemi Seyed Mohammad, et al. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2019 0 68
• MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome.
  Li Miao-Nan, et al. Medicine 2017 12 (49) e9044
• Familial Hypercholesterolemia: What Is It and Who Gets It?
  By Jessica Mao, M.D., Erin Michos, M.D., M.H.S., Vasanth Sathiyakumar, M.D., Cat Davis Ahmed, and Seth Martin, M.D., U.S. News, July 11, 2019
• Association study of matrix metalloproteinase 3 5A/6A polymorphism with in-stent restenosis after percutaneous coronary interventions in a Han Chinese population.
  Du Ji-Bing, et al. The Journal of international medical research 2019 2 300060519827145
• High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention.
  Golukhova E Z, et al. Kardiologiia 2018 11 (4) 5-14
• Advanced Endoscopic Navigation: Surgical Big Data, Methodology, and Applications.
  Luo Xiongbiao et al. Annual review of biomedical engineering 2018 20221-251
• [High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention].
  Golukhova E Z, et al. Kardiologiia 2018 4 (4) 5-14
• Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
  Ozawa Takuya, et al. International heart journal 2017 12

More